iiinova — where your digital self keeps evolving

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 31/12/2025

The MARKUS@HOMe editorial team wishes all colleagues a happy New Year's Eve 2025 and a happy, healthy, peaceful, and safe 2026. We thank all our guests for their academic contributions and look forward to seeing you again in 2026! youtu.be/hcRC-UQokhs?...

youtu.be

Neujahr 2026

YouTube video by MARKUS at HOMe

032

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 06/01/2026

Age-Adjusted D-Dimer Cutoff Levels to Rule Out Deep Vein Thrombosis by Drs. Le Gal, Righini et al. The age-adjusted D-dimer cutoff may safely rule out DVT and was associated with a larger number of patients in whom DVT could be effectively ruled out. jamanetwork.com/journals/jam...

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 08/01/2026

Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a) by Drs. Nordestgaard, Ridker et al. Very high Lp(a) levels correlated with increased 30-year risk of CV disease among healthy women. jamanetwork.com/journals/jam...

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 09/01/2026

Finally, the time has come: Nephrology / Hypertension 2025 II ...simultaneously with our 6000th follower! Who will be on the winner's podium? youtu.be/W_1GjTPD29E?...

youtu.be

Nephrologie / Hypertensiologie 2025 II

YouTube video by MARKUS at HOMe

032

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 23/12/2025

Short-Term DOAC vs. DAPT for Preventing Device Thrombosis Following LAA-Closure: The ANDES RCT by Drs. Rodés-Cabau, Salaun et al. www.ahajournals.org/doi/10.1161/... The use of DOACs after LAAC failed to reduce DRT compared with DAPT, but it was associated with an improved safety profile.

011

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 25/12/2025

The MARKUS@HOME editorial team wishes all colleagues a peaceful and blessed Christmas 2025. Thank you for your interest in our webinars. We look forward to seeing you again in 2026! youtu.be/P64PnU0WyZE?...

youtu.be

Weihnachten 2025

YouTube video by MARKUS at HOMe

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 26/12/2025

In our special Christmas episode, Mr. Reinhard Ernst (Wiesbaden) discusses the importance of access to abstract art in general and to abstract expressionism in painting in particular for people in Germany in 2026 youtu.be/HZPtOtj_058?...

youtu.be

Abstrakte Kunst für Alle? - Reinhard Ernst (Wiesbaden)

YouTube video by MARKUS at HOMe

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 30/12/2025

Our top-rated cardiology study of 2025 (Best of cardiology: youtu.be/FAOH0tL2Cy8?...) Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction by Drs. Bavendiek, Bauersachs et al. www.nejm.org/doi/full/10....

011

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 20/11/2025

Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD) by Drs. Johansen, Biering-Sørensen et al. www.thelancet.com/journals/lan... In this analysis, HD-IIV demonstrated superior protection compared with SD-IIV.

011

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 21/11/2025

Extended DOAC Therapy in Provoked VTE - HI-PRO - Prof. Behnood Bikdeli, Prof. Romain Didier @bbikdeli.bsky.social youtu.be/e0Orc_Ps56U?...

youtu.be

Extended DOAC Therapy in Provoked VTE - HI-PRO - Prof. Behnood Bikdeli, Prof. Romain Didier

YouTube video by MARKUS at HOMe

032

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 27/11/2025

High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease by Drs. Bartholdy, Biering-Sørensen et al. www.jacc.org/doi/10.1016/... In this prespecified analysis of DANFLU-2 a benefit of HD-IIV over SD-IIV was observed.

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 28/11/2025

Trends in CVE & Bleeding in Advanced CKD: SRR - Dr. M. Evans, Dr. A.-L. Faucon (Stockholm, Sweden) youtu.be/S2hbWPWkzcU?...

youtu.be

Trends in CVE & Bleeding in Advanced CKD: SRR - Dr. M. Evans, Dr. A.-L. Faucon (Stockholm, Sweden)

YouTube video by MARKUS at HOMe

041

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 04/12/2025

VALIANT: Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN by Drs. Fakhouri, Nester et al. www.nejm.org/doi/full/10.... Pegcetacoplan resulted in a significantly greater reduction in proteinuria than placebo among patients with C3 GN or primary immune-complex MPGN.

nejm.org

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN | NEJM

C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis (MPGN) generally result in glomerular C3 deposition and irreversible kidney damage. The efficacy and safety of ...

022

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 05/12/2025

Tonight: Antithrombotic Therapy in ASCVD + VTE: AQUATIC - Prof. Behnood Bikdeli, Prof. Romain Didier youtu.be/w8qCX2pRSxQ?... @bbikdeli.bsky.social

youtu.be

Antithrombotic Therapy in ASCVD + VTE: AQUATIC - Prof. Behnood Bikdeli, Prof. Romain Didier

YouTube video by MARKUS at HOMe

021

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 17/12/2025

Exercise and Kidney Health: Core Curriculum 2026 by Drs. Becerra, Mansour. www.ajkd.org/article/S027... This core curriculum reviews the physiology of exercise on kidney function and provides evidence-based strategies for patient counseling and risk reduction.

041

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 18/12/2025

Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes by Drs. Nicholls, D’Alessio et al. www.nejm.org/doi/full/10.... Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide.

021

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 19/12/2025

It's that time again: Best of Cardiologie 2025 youtu.be/FAOH0tL2Cy8?... Watch now!

youtu.be

Best of Cardiologie 2025

YouTube video by MARKUS at HOMe

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 05/09/2025

It's Congress-Update time! Check out our new webinar "Post ESC 2025"! youtu.be/6C6lJWUHlc8?...

youtu.be

Post ESC 2025

YouTube video by MARKUS at HOMe

054

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 07/09/2025

Last days of summer...

011

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 14/10/2025

Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes by Drs. Herrington, Staplin et al. www.sciencedirect.com/science/arti... SGLT2 I reduces the risk of acute and chronic kidney outcomes irrespective of the size of the acute dip in eGFR.

072

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 16/10/2025

Fractional flow reserve-guided renal artery stenting in atherosclerotic renovascular hypertension: the FAIR randomized trial by Drs. Li, Li et al. academic.oup.com/eurheartj/ar... BP and antihypertensive medication usage decreased significantly after stenting in patients with FFR < 0.80

022

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 17/10/2025

Novel developments in the treatment of HFrEF - Prof. Dr. John McMurray (Glasgow, UK) youtu.be/kK8N-5RkEfc?... Prof. McMurray discusses new developments in the treatment of HFrEF, focusing on new outcome data for vericiguat and digitoxin from the VICTOR and DIGIT-HF studies.

youtu.be

Novel developments in the treatment of HFREF - Prof. Dr. John McMurray (Glasgow, UK)

YouTube video by MARKUS at HOMe

011

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 23/10/2025

A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus by Drs. van Vollenhoven, Zhang et al. www.nejm.org/doi/full/10.... The incidence of a clinical response was higher with telitacicept (a new dual inhibitor of the cytokines B-lymphocyte stimulator and APRIL) than with placebo.

041

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 24/10/2025

Our experts explain: CKD of unexplained cause: ERA G & K Consensus - Prof. @ecorneclegall.bsky.social, Prof. Halbritter, Prof. Müller youtu.be/RzupTGtHs8g?... They present the CKDx consensus statement of the ERA Genes & Kidney Working Group, published in NDT.

youtu.be

CKD of unexplained cause: ERA G & K Consensus - Prof. Cornec-Le Gall, Prof. Halbritter, Prof. Müller

YouTube video by MARKUS at HOMe

021

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 28/10/2025

Urinary tract infection and continuation of SGLT-I in diabetic patients by Drs. Wu, Yiu et al. academic.oup.com/eurheartj/ar... Discontinuing SGLT2 inhibitors after a UTI was linked to a higher risk of cardiovascular and renal outcomes but was not associated with fewer recurrent UTI.

142

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 31/10/2025

Stream it now! Our webinar in cooperation with NDT: IgA-NP: Treatment Standard & Future Perspective - Prof. Jonathan Barratt, Prof. Jai Radhakrishnan @ndt-era.bsky.social @kronbichlerlab.bsky.social @gunnarheine.bsky.social @hjanders.bsky.social youtu.be/l0g9_lkW5_w?...

youtu.be

IgA-NP: Treatment Standard & Future Perspective - Prof. Jonathan Barratt, Prof. Jai Radhakrishnan

YouTube video by MARKUS at HOMe

085

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 30/10/2025

Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury The BICARICU-2 Randomized Clinical Trial by Drs. Jung, Jaber et al. jamanetwork.com/journals/jam... In this randomized trial infusion of sodium bicarbonate did not improve 90-day mortality.

043

Reposted by Gunnar Heine

Deutsche Gesellschaft für Nephrologie e.V. (DGfN) @dgfn.bsky.social · 14/10/2025

New DGfN Board elected! Prof. Julia Weinmann-Menke joins the board of the German Society of Nephrology. Prof. Martin K. Kuhlmann (President), Prof. Elke Schäffner and PD Dr. Georg Schlieper were re-elected. More info 👉 www.dgfn.eu/vorstand.html #Nephrology #DGfN #CKD

012

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 16/09/2025

How to diagnose and treat superficial vein thrombosis (SuVT) by Drs. Piazza, Bikdeli et al. jamanetwork.com/journals/jam...

021

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 18/09/2025

KDIGO publishes its new guidelines on IgA Nephropathy (IgAN) / IgA Vasculitis (IgAV) kdigo.org/guidelines/i...

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 19/09/2025

Primäre Hyperoxalurie - Prof. Dr. Bernd Hoppe (Bonn) Prof. Dr. Bernd Hoppe explains the pathophysiology, diagnostics, current and possible future therapies of primary hyperoxaluria. youtu.be/T18mxSSlG7g?...

youtu.be

Primäre Hyperoxalurie - Prof. Dr. Bernd Hoppe (Bonn)

YouTube video by MARKUS at HOMe

022

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 24/09/2025

Anti-glomerular Basement Membrane Disease - Treatment Standard by Drs. McAdoo, Pusey et al. academic.oup.com/ndt/article/...

032

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 26/09/2025

Atypical Hemotytic Uremic Syndrome (aHUS) - Prof. Fadi Fakhouri (Lausanne, Switzerland) youtu.be/k0UlfUh_PZU?... Prof. Fakhouri discusses pathophysiology, diagnosis, treatment and prognosis of atypical Hemolytic Uremic Syndrome (aHUS).

youtu.be

Atypical Hemotytic Uremic Syndrome (aHUS) - Prof. Fadi Fakhouri (Lausanne, Switzerland)

YouTube video by MARKUS at HOMe

062

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 01/10/2025

Abnormal electrocardiogram findings in athletes by Drs. Finocchiaro, D’Ascenzi et al. A consensus statement of the European Association of Preventive Cardiology of the European Society of Cardiology! academic.oup.com/eurheartj/ar...

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 05/10/2025

Impfungen 25 / 26: Influenza, SARS-CoV-2, RSV, Pneumokokken - Prof. Dr. Klaus Stöhr, Prof. Dr. Barbara Gärtner youtu.be/V5P-eDvf9jI?...

youtu.be

Impfungen 25 / 26: Influenza, SARS-CoV-2, RSV - Prof. Dr. Klaus Stöhr, Prof. Dr. Barbara Gärtner

YouTube video by MARKUS at HOMe

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 07/10/2025

Transthyretin amyloid cardiomyopathy: from cause to novel treatments by Drs. Fontana, Gillmore et al. academic.oup.com/eurheartj/ar...

011

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 09/10/2025

The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference by Drs. Furth, Rossing et al. www.kidney-international.org/article/S008...

042

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 17/08/2025

Where the sea meets the sky, peace begins

011

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 15/08/2025

Extended reduced-dose DOAC: APICAT / RENOVE - Prof. Isabelle Mahé / Prof. Francis Couturaud youtu.be/RXttWKQ-sM4?... Prof Mahé and Prof. Couturaud discuss the use of reduced-dose NOAC treatment for extended treatment of VT, based upon their APICAT and RENOVE trials.

youtu.be

Extended reduced-dose DOAC: APICAT / RENOVE - Prof. Isabelle Mahé / Prof. Francis Couturaud

YouTube video by MARKUS at HOMe

021

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 14/08/2025

A Crossover Trial of Hospital-Wide Lactated Ringer’s Solution versus Normal Saline by Drs. McIntyre, Taljaard et al. www.nejm.org/doi/full/10.... Lactated Ringer’s solution rather than normal saline did not result in a lower incidence of death or readmission to the hospital.

031

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 01/08/2025

Our new webinar is now available! Schlaganfall: Update für Internisten 2025 - Prof. Dr. Christoph Kleinschnitz (Essen) youtu.be/vGdg_YIf7uc?...

youtu.be

Schlaganfall: Update für Internisten 2025 - Prof. Dr. Christoph Kleinschnitz (Essen)

YouTube video by MARKUS at HOMe

011

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 03/08/2025

And the wheel keeps turning...

021

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 05/08/2025

Kidney function trajectories before and after hospitalization for HFrEF by Drs. Kobayashi, Girerd et al. academic.oup.com/eurheartj/ar... In HFrEF, kidney function decline may precede a HF events by up to one year. Monitoring eGFR slopes may allow early detection of patients at risk.

043

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 07/08/2025

2025 Concise Clinical Guidance: An ACC Expert Consensus Statementon the Diagnosis and Management of Pericarditis A Report of the American College of Cardiology Solution Set Oversight Committee www.jacc.org/doi/epdf/10....

022

Reposted by Gunnar Heine

markusathome @markusathome.bsky.social · 08/08/2025

It's Friday again! Posttransplantations-Lymphome - Priv.-Doz. Dr. Florian Kocher, Prof. Dr. Dominik Wolf (Innsbruck) youtu.be/t3mWguKpq7E?...

youtu.be

Posttransplantations-Lymphome - Priv.-Doz. Dr. Florian Kocher, Prof. Dr. Dominik Wolf (Innsbruck)

YouTube video by MARKUS at HOMe

011